Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 11 - 20 of about 183   

Articles published

AZN 4,415.50 -71.00 (-1.58%)
price chart
Is It Game Over For AstraZeneca plc Shareholders?
�They (regulators) already scuppered the Abbvie/Shire takeover, and since Pfizer/AstraZeneca was a similar tax-driven move there's no reason to expect Pfizer to re-enter the bidding, at least not at anywhere near the previous price, since a combination ...
AstraZeneca plc vs Smith & Nephew plc: Which Is The Better Buy?
Today's updates from AstraZeneca (LSE: AZN) (NYSE: AZN.US) and Smith & Nephew (LSE: SN) (NYSE: SNN.US) show that both companies are in the midst of transitional periods.
Form 6-K ASTRAZENECA PLC For: Feb 05
AstraZeneca Earnings Miss Estimates as Sales of Drugs Slip  Bloomberg
How Safe Are GlaxoSmithKline plc And AstraZeneca plc's Dividends?
US) and AstraZeneca (LSE: AZN)(NYSE: AZN.US) have traditionally been seen as solid cash generators, but the shine wore off them a little as they both struggled with the expiry of patent protection on key drugs and the increase in competition from generics.
Should You Follow Neil Woodford And Buy GlaxoSmithKline plc, AstraZeneca ...
Neil Woodford has been an investor in the pharmaceuticals industry for most of his long career. In a recent blog, the ace fund manager wrote: "The pharmaceuticals sector is no longer as cheap as it was but it still looks very attractive in my view ...
3 Reasons I Believe GlaxoSmithKline plc Is One Step Ahead Of AstraZeneca plc
Back in 2012, AstraZeneca (LSE: AZN) (NYSE: AZN.US) was priced for disaster. Investors expected the firm's profits to fall off the patent cliff, and the firm's shares were trading on a trailing P/E of around 6 times earnings, with a yield of more than 6%.
Should You Buy AstraZeneca plc Instead Of Hikma Pharmaceuticals Plc, BTG ...
2015 has been a rather mixed year thus far for the pharmaceutical sector. That's because, while the likes of AstraZeneca (LSE: AZN) (NYSE: AZN.US) and BTG (LSE: BTG) have seen their share prices fall by 1.5% and 1% respectively, superb gains have been ...
Is Now A Good Time To Buy AstraZeneca plc?
A casual observer might conclude that AstraZeneca's (LSE: AZN) (NYSE: AZN.US) full-year results for 2014 could disappoint investors.
Recent Research Analysts' Ratings Updates for AstraZeneca plc (AZN)
AstraZeneca plc (NYSE:AZN) opened at 68.73 on Tuesday. AstraZeneca plc has a 52-week low of $61.80 and a 52-week high of $82.68.
AstraZeneca plc Dreams Big Again: R&D Spin-Off Born
British drug manufacturer AstraZeneca plc (ADR) (NYSE:AZN) has made the final decision to heave off its antibiotic segment into an independent subsidiary.
Share Price of Astrazeneca PLC Rally 0.47%  Winston View
Form 6-K ASTRAZENECA PLC For: Mar 03
As previously announced, the strategic transaction strengthens AstraZeneca's respiratory franchise globally and builds on the acquisition of Almirall's respiratory portfolio in 2014 by extending the company's development and commercialisation rights ...